FEAT APPLICATIONThe FEAT grant program is currently in pilot with the goal of raising $1M or $10K per individual treatment to take 100 applicants through an ibogaine (or other entheogenic medicine) addiction treatment with medical oversight provided by Dr. Jeffrey Kamlet, ibogaine and addiction medicine expert and Awake.net founding Board member.
This grant provides detox, treatment, and integration funds, and guidance for individuals seeking treatment with ibogaine or other entheogenic protocols for opioid or other hard addictions, as well as trauma, depression, meaninglessness, and other mood disorders. The grant is for $10,000. We require that you raise/pay an additional $2,000 by your own efforts, $900 of which will be required upon acceptance to the program to pay for the nine-month course.
NOTE: We know that substance abuse disorders create financial difficulty. Our intention in requiring immediate payment is not to make it difficult but because the $900 is an expression of your commitment and intention to heal, and is therefor the first step.WHO DOES THE TREATMENT?
The grants are disbursed directly to the ibogaine clinics and/or integration providers selected from an approved list of providers.ABOUT IBOGAINE:
Iboga/ibogaine is an entheogenic/psychedelic plant medicine that can interrupt opioid addiction in a single treatment without withdrawal. Ibogaine is called the "addiction interruptor" because it actually restores the physiology (receptors and brain neurons) to a "pre-addicted" state. When coupled with an integration aftercare program it can be a powerful medicine for addiction recovery that affects body, mind, and spirit. It needs to be administered with clinical and therapeutic care and customized detox protocols depending on which cocktail of drugs, legal or illegal, the person might be on. Ibogaine also requires an aftercare integration plan in order for the "interruption" to become a permanent reset. As one ibogaine clinic owner says: "You have to change one thing: Everything."
Because ibogaine is classified as a Schedule One drug with "no medicinal value" it is off limits in the US and Canada, the home of the opioid epidemic. Many clinics have sprung up in Mexico, Europe, Africa, New Zealand, and elsewhere to treat opioid addiction with ibogaine. However, because it's not covered by insurance in the US/Canada, people cannot afford the cost of travel, treatment, and integration. Hence this grant. The FEAT grant was created as a part of the Iboga Saves campaign to end the opioid epidemic by Awake.net, a non-profit pending 501c3 corporation.
"*" indicates required fields